{"disease":{"id":"hiv-seronegativity","name":"hiv seronegativity"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00031304","title":"Screening Protocol for HIV Vaccine Studies","phase":"","overall_status":"COMPLETED","enrollment_count":1324,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT01761643","title":"CCTG 595: Text Messaging Intervention to Improve Adherence to PrEP in High-risk MSM","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":398,"lead_sponsor_name":"University of California, San Diego","has_results":true},{"nct_id":"NCT03086200","title":"Randomized Controlled Trial of iTAB Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals","phase":"NA","overall_status":"COMPLETED","enrollment_count":263,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT03995862","title":"Evaluation of Pre-Exposure Prophylaxis Against HIV in Alpine Region","phase":"","overall_status":"COMPLETED","enrollment_count":242,"lead_sponsor_name":"Centre Hospitalier Annecy Genevois","has_results":false},{"nct_id":"NCT03191474","title":"Linkage of Transgender Individuals to PrEP","phase":"NA","overall_status":"COMPLETED","enrollment_count":202,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT01418235","title":"Safety of and Immune Response to a DNA HIV Vaccine Boosted With a Modified Vaccinia HIV Vaccine and Protein HIV Vaccine in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":184,"lead_sponsor_name":"HIV Vaccine Trials Network","has_results":false},{"nct_id":"NCT02125773","title":"Pre-exposure Prophylaxis Accessibility Research and Evaluation 2","phase":"NA","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT00047931","title":"HIV-1 Vaccine Test in Uninfected Adult Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT00055237","title":"Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT00000809","title":"Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT00001046","title":"Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT00078182","title":"Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia","phase":"PHASE2, PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}